HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan L Tucker Selected Research

Conformal Radiotherapy

1/2016Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation.
11/2010Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
3/2010Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
3/2010Radiation dose-volume effects in radiation-induced rectal injury.
12/2006Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
9/2006Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
12/2005Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.
7/2005Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.
12/2004Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
6/2004Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan L Tucker Research Topics

Disease

47Neoplasms (Cancer)
01/2017 - 01/2002
31Breast Neoplasms (Breast Cancer)
01/2017 - 01/2002
23Prostatic Neoplasms (Prostate Cancer)
08/2014 - 08/2003
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 05/2003
7Radiation Pneumonitis
01/2019 - 07/2009
7Esophageal Neoplasms (Esophageal Cancer)
04/2014 - 12/2005
6Neoplasm Metastasis (Metastasis)
01/2013 - 11/2002
4Lung Neoplasms (Lung Cancer)
05/2014 - 05/2003
4Pneumonia (Pneumonitis)
06/2009 - 12/2006
3Genomic Instability
02/2010 - 05/2004
3Pathologic Complete Response
08/2008 - 10/2005
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2005 - 10/2003
3Hemorrhage
07/2005 - 06/2004
2Ovarian Neoplasms (Ovarian Cancer)
06/2014 - 08/2007
2Esophagitis
11/2012 - 09/2006
2Melanoma (Melanoma, Malignant)
08/2006 - 07/2005
2Extranodal Extension
09/2005 - 06/2005
2Weight Loss (Weight Reduction)
12/2004 - 07/2004
2Lymphoma (Lymphomas)
01/2004 - 02/2002
2Hodgkin Disease (Hodgkin's Disease)
01/2003 - 12/2002
1Noninfiltrating Intraductal Carcinoma (DCIS)
10/2015
1Anastomotic Leak
04/2014
1Brain Neoplasms (Brain Tumor)
08/2013
1Medulloblastoma
06/2013
1Pain (Aches)
01/2013
1Transitional Cell Carcinoma
04/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2012
1Deglutition Disorders (Dysphagia)
12/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2010
1Oropharyngeal Neoplasms
12/2010
1Hypertension (High Blood Pressure)
11/2010
1Pericardial Effusion
03/2008
1Disease Progression
01/2008
1Inflammatory Breast Neoplasms
07/2007

Drug/Important Bio-Agent (IBA)

10Estrogen ReceptorsIBA
01/2017 - 10/2003
9Doxorubicin (Adriamycin)FDA LinkGeneric
05/2009 - 02/2002
8Biomarkers (Surrogate Marker)IBA
07/2016 - 06/2002
7Cyclin EIBA
04/2012 - 11/2002
6Hormones (Hormone)IBA
10/2015 - 08/2003
5Prostate-Specific Antigen (Semenogelase)IBA
01/2008 - 08/2003
4Trastuzumab (Herceptin)FDA Link
03/2016 - 05/2009
4Protein Isoforms (Isoforms)IBA
04/2012 - 11/2002
4Proteins (Proteins, Gene)FDA Link
05/2009 - 09/2003
3TamoxifenFDA LinkGeneric
10/2015 - 01/2002
3Biological ProductsIBA
06/2014 - 12/2006
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013 - 07/2009
3Phosphotransferases (Kinase)IBA
04/2012 - 08/2007
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2004 - 02/2002
2Protons (Proton)IBA
08/2013 - 06/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 12/2004
2Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2012 - 05/2004
2Progesterone Receptors (Progesterone Receptor)IBA
04/2011 - 08/2010
2human ERBB2 proteinIBA
08/2010 - 01/2009
2Histone Deacetylase InhibitorsIBA
08/2006 - 07/2005
2Dihydrotachysterol (AT 10)IBA
07/2006 - 10/2005
2Vincristine (Oncovin)FDA LinkGeneric
01/2004 - 02/2002
2Prednisone (Sone)FDA LinkGeneric
01/2004 - 02/2002
1Biological FactorsIBA
07/2016
1antineoplaston A10 (A 10)IBA
06/2014
1NAD (NADH)IBA
10/2013
1AndrogensIBA
10/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2013
1Antigen-Antibody Complex (Immune Complex)IBA
04/2012
1Cyclin-Dependent Kinase 2IBA
04/2012
1ParaffinIBA
03/2012
1BariumIBA
12/2010
1Estrogens (Estrogen)FDA Link
08/2010
1RoscovitineIBA
02/2010
1Letrozole (Femara)FDA LinkGeneric
02/2010
1Aromatase InhibitorsIBA
02/2010
1Fulvestrant (Faslodex)FDA Link
02/2010
1Transforming Growth Factor beta (TGF-beta)IBA
07/2009
1Lapatinib (GW572016)FDA Link
05/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2009
1Integrin alpha6beta4IBA
01/2009
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
01/2009
1Tumor Biomarkers (Tumor Markers)IBA
01/2008
1PlatinumIBA
08/2007
1Histone Deacetylases (Histone Deacetylase)IBA
08/2006
1VorinostatFDA Link
08/2006
1ChromatinIBA
08/2006

Therapy/Procedure

54Radiotherapy
01/2019 - 02/2002
26Drug Therapy (Chemotherapy)
01/2016 - 02/2002
22Therapeutics
03/2016 - 08/2003
15Neoadjuvant Therapy
01/2017 - 01/2002
12Conformal Radiotherapy
01/2016 - 03/2004
9Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2014 - 03/2004
8Mastectomy (Mammectomy)
05/2009 - 01/2002
7Chemoradiotherapy
01/2013 - 04/2004
4Proton Therapy
01/2019 - 11/2012
4Aftercare (After-Treatment)
07/2016 - 05/2003
2Adjuvant Chemotherapy
08/2010 - 07/2002
2Particle Accelerators
05/2008 - 07/2004
2Induction Chemotherapy
03/2008 - 12/2003
2Lymphatic Irradiation
09/2005 - 10/2003
1Brachytherapy
06/2014
1Craniospinal Irradiation
06/2013
1Simple Mastectomy
01/2009
1Patient Positioning
05/2008
1Combined Modality Therapy
06/2007